NMDA receptor pathways as drug targets.

Area of Science:

• Neuroscience
• Pharmacology
• Drug Development

Background:

• Significant academic and industrial interest exists in NMDA receptor antagonist drugs since the mid-1980s.
• The therapeutic potential of targeting NMDA receptor pathways for neurological conditions has been recognized for decades.
• Effective treatments for major disorders like stroke and Alzheimer's disease remain a critical unmet medical need.

Purpose of the Study:

• To review the historical reasons behind the slow translation of NMDA receptor drug development.
• To critically assess the future prospects of NMDA receptor pathway-acting drugs.
• To explore potential therapeutic applications for neurological disorders, including stroke and Alzheimer's disease.

Main Methods:

• Literature review of academic and industry research on NMDA receptor drugs.
• Critical analysis of historical challenges in drug development.
• Assessment of current and future therapeutic potential for specific neurological conditions.

Main Results:

• Early enthusiasm for NMDA receptor drugs has been slow to yield approvable therapies.
• Several factors have contributed to the delayed progress in this field.
• Emerging data suggests a renewed potential for these drugs in treating neurological disorders.

Conclusions:

• Despite historical challenges, NMDA receptor-targeted therapies are beginning to show promise.
• Future research and development efforts are crucial for realizing the full therapeutic potential.
• NMDA receptor drugs may offer novel treatment options for debilitating conditions like stroke and Alzheimer's disease.